Difference between revisions of "DZI19-11"

From MGH Learn Pathology
(Automatic edit to upgrade to new templates)
(Updating subject, access, and performer)
 
(2 intermediate revisions by the same user not shown)
Line 9: Line 9:
 
|supportingInfo=Dermatopathology
 
|supportingInfo=Dermatopathology
 
|reasonCode=Cutaneous Toxicities of Drugs
 
|reasonCode=Cutaneous Toxicities of Drugs
|subject=public
+
|subject=MGH
|performer=Rmn6
+
|performer=RMN6
 
|authoredOn=March 24, 2019 05:26:11 PM
 
|authoredOn=March 24, 2019 05:26:11 PM
 
|requester=Em99
 
|requester=Em99
 +
|access=public
 
}}
 
}}
 
{{status
 
{{status
 
|status=completed
 
|status=completed
|authoredOn=March 09, 2022 01:44:44 PM
+
|authoredOn=March 10, 2022 11:19:30 AM
 
|requester=Si787
 
|requester=Si787
 
|identifier=DZI19-11
 
|identifier=DZI19-11
 
}}
 
}}

Latest revision as of 15:21, June 21, 2022


Request type Study
Subspecialty Dermatopathology
Set RMN Dermpath Teaching Set
Topic Cutaneous Toxicities of Drugs
Presenter Nazarian, Rosalynn M.,MD


Toggle columns: Diagnosis

Case Clinical history Requester Diagnosis
Case Clinical history Requester Diagnosis

Case 1


None provided Em99 Localized argyria with pseudoochronosis

Case 2


None provided Em99 TEN jelly roll

Case 3


None provided Em99 Admixed melanin and minocycline pigmentation

Case 4


None provided Em99 Severe erythema multiforme (Lamictal)

Case 5


None provided Em99 Fixed drug eruption